alfaxalone (BioDeep_00000009590)

   


代谢物信息卡片


3-Hydroxypregnane-11,20-dione

化学式: C21H32O3 (332.2351)
中文名称: 阿法沙龙
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CC(=O)C1CCC2C1(CC(=O)C3C2CCC4C3(CCC(C4)O)C)C
InChI: InChI=1S/C21H32O3/c1-12(22)16-6-7-17-15-5-4-13-10-14(23)8-9-20(13,2)19(15)18(24)11-21(16,17)3/h13-17,19,23H,4-11H2,1-3H3/t13-,14+,15-,16+,17-,19+,20-,21+/m0/s1

描述信息

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics
N - Nervous system > N01 - Anesthetics > N01A - Anesthetics, general
C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent
D018377 - Neurotransmitter Agents > D000081227 - Neurosteroids

同义名列表

4 个代谢物同义名

Alphaxalone; alfaxalone; 3-Hydroxypregnane-11,20-dione; Alphaxalone



数据库引用编号

13 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表
Cytoplasm 5 CA1, CASP3, IL1A, NFKB1, POMC
Peripheral membrane protein 1 CYP1B1
Endosome membrane 1 CLCN5
Endoplasmic reticulum membrane 2 CD4, CYP1B1
Nucleus 3 CASP3, IL1A, NFKB1
cytosol 7 CA1, CASP3, CLCN5, GPT, IL1A, NFKB1, PRKCQ
nucleoplasm 3 CASP3, NFKB1, SCNN1G
Cell membrane 4 CD4, CD8A, CLCN5, TNF
Multi-pass membrane protein 2 CLCN5, SCNN1G
Golgi apparatus membrane 1 CLCN5
Synapse 1 CRH
cell surface 2 IL1A, TNF
glutamatergic synapse 1 CASP3
Golgi apparatus 1 CLCN5
Golgi membrane 2 CLCN5, INS
lysosomal membrane 1 CLCN5
neuronal cell body 2 CASP3, TNF
synaptic vesicle 1 CLCN5
plasma membrane 8 CD4, CD8A, CLCN5, CSF2, IFNLR1, PRKCQ, SCNN1G, TNF
Membrane 3 CLCN5, CYP1B1, IFNLR1
apical plasma membrane 1 SCNN1G
extracellular exosome 3 CA1, GPT, SCNN1G
extracellular space 9 CRH, CSF2, IFNA1, IL1A, IL2, IL6, INS, POMC, TNF
mitochondrion 2 CYP1B1, NFKB1
intracellular membrane-bounded organelle 2 CSF2, CYP1B1
Microsome membrane 1 CYP1B1
postsynaptic density 1 CASP3
Single-pass type I membrane protein 3 CD4, CD8A, IFNLR1
Secreted 8 CRH, CSF2, IFNA1, IL1A, IL2, IL6, INS, POMC
extracellular region 10 CD8A, CRH, CSF2, IL1A, IL2, IL6, INS, NFKB1, POMC, TNF
[Isoform 2]: Secreted 1 CD8A
transcription regulator complex 1 NFKB1
centriolar satellite 1 PRKCQ
external side of plasma membrane 4 CD4, CD8A, SCNN1G, TNF
varicosity 1 CRH
neuronal dense core vesicle lumen 1 CRH
perikaryon 1 CRH
Early endosome 2 CD4, CLCN5
apical part of cell 1 CLCN5
recycling endosome 1 TNF
Single-pass type II membrane protein 1 TNF
Apical cell membrane 1 SCNN1G
Membrane raft 2 CD4, TNF
secretory granule 1 POMC
receptor complex 1 CD8A
chromatin 1 NFKB1
phagocytic cup 1 TNF
endosome lumen 1 INS
sodium channel complex 1 SCNN1G
plasma membrane raft 1 CD8A
secretory granule lumen 3 INS, NFKB1, POMC
Golgi lumen 1 INS
endoplasmic reticulum lumen 3 CD4, IL6, INS
specific granule lumen 1 NFKB1
transport vesicle 1 INS
Endoplasmic reticulum-Golgi intermediate compartment membrane 1 INS
immunological synapse 1 PRKCQ
aggresome 1 PRKCQ
clathrin-coated endocytic vesicle membrane 1 CD4
death-inducing signaling complex 1 CASP3
[Isoform 1]: Cell membrane 1 CD8A
granulocyte macrophage colony-stimulating factor receptor complex 1 CSF2
[Tumor necrosis factor, soluble form]: Secreted 1 TNF
T cell receptor complex 2 CD4, CD8A
interleukin-6 receptor complex 1 IL6
[Nuclear factor NF-kappa-B p105 subunit]: Cytoplasm 1 NFKB1
[Nuclear factor NF-kappa-B p50 subunit]: Nucleus 1 NFKB1
I-kappaB/NF-kappaB complex 1 NFKB1
NF-kappaB p50/p65 complex 1 NFKB1
interleukin-28 receptor complex 1 IFNLR1
[C-domain 2]: Secreted 1 TNF
[Tumor necrosis factor, membrane form]: Membrane 1 TNF
[C-domain 1]: Secreted 1 TNF


文献列表

  • Kayla Hasse, Amanda Crawford, Daniel Gustafson, Sangeeta Rao, Eric Klaphake, Matthew Johnston. PLASMA CONCENTRATION AND PHARMACODYNAMICS OF INTRAMUSCULAR ADMINISTRATION OF ALFAXALONE IN INDIAN PEAFOWL (PAVO CRISTATUS). Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians. 2022 Mar; 53(1):108-115. doi: 10.1638/2020-0220. [PMID: 35339155]
  • Ciara A Barr, Fabio Alvarado, Yu-Mei Chang, Jie Luo, Oliver A Garden. The impact of alfaxalone, propofol and ketamine on canine peripheral blood lymphocyte cytotoxicity in vitro. Research in veterinary science. 2021 May; 136(?):182-184. doi: 10.1016/j.rvsc.2021.02.019. [PMID: 33676156]
  • I D Yozova, H Sano, K Weidgraaf, E J Candy, J F Cockrem. A randomized cross-over trial assessing salivary and urinary cortisol concentrations after alfaxalone and propofol administration in healthy cats. Domestic animal endocrinology. 2021 01; 74(?):106557. doi: 10.1016/j.domaniend.2020.106557. [PMID: 33039929]
  • Gareth E Zeiler, Andrea Fuller, Eva Rioja, Peter Kamerman, Roxanne K Buck, Friederike Pohlin, Brighton T Dzikiti. Development of a severity scoring system for acute haemorrhage in anaesthetized domestic cats: the CABSS score. Veterinary anaesthesia and analgesia. 2020 Jul; 47(4):499-508. doi: 10.1016/j.vaa.2019.11.008. [PMID: 32507719]
  • Pedro Marín, Eliseo Belda, Francisco G Laredo, Crhystian A Torres, Verónica Hernandis, Elisa Escudero. Pharmacokinetics and sedative effects of alfaxalone with or without dexmedetomidine in rabbits. Research in veterinary science. 2020 Apr; 129(?):6-12. doi: 10.1016/j.rvsc.2019.12.015. [PMID: 31901533]
  • Colin S Goodchild, Juliet M Serrao, John W Sear, Brian J Anderson. Pharmacokinetic and Pharmacodynamic Analysis of Alfaxalone Administered as a Bolus Intravenous Injection of Phaxan in a Phase 1 Randomized Trial. Anesthesia and analgesia. 2020 03; 130(3):704-714. doi: 10.1213/ane.0000000000004204. [PMID: 31124836]
  • Tamara N Kruse, Kristen M Messenger, Andrew S Bowman, Turi K Aarnes, Thomas E Wittum, Mark Flint. Pharmacokinetics and pharmacodynamics of alfaxalone after a single intramuscular or intravascular injection in mallard ducks (Anas platyrhynchos). Journal of veterinary pharmacology and therapeutics. 2019 Nov; 42(6):713-721. doi: 10.1111/jvp.12804. [PMID: 31435964]
  • Bruno H Pypendop, Linda S Barter, Peter J Pascoe, M G Ranasinghe, Kirby Pasloske. Hemodynamic effects of subclinical, clinical and supraclinical plasma alfaxalone concentrations in cats. Veterinary anaesthesia and analgesia. 2019 Sep; 46(5):597-604. doi: 10.1016/j.vaa.2019.05.004. [PMID: 31303447]
  • Julie A Balko, Dana M Lindemann, Matthew C Allender, Sathya K Chinnadurai. Evaluation of the anesthetic and cardiorespiratory effects of intramuscular alfaxalone administration and isoflurane in budgerigars (Melopsittacus undulatus) and comparison with manual restraint. Journal of the American Veterinary Medical Association. 2019 06; 254(12):1427-1435. doi: 10.2460/javma.254.12.1427. [PMID: 31149875]
  • Ai Wakuno, Motoki Aoki, Asuka Kushiro, Naomi Mae, Tatsuya Maeda, Yosuke Yamazaki, Yohei Minamijima, Shun-Ichi Nagata, Minoru Ohta. Clinical pharmacokinetics and pharmacodynamics of intravenous alfaxalone in young Thoroughbred horses premedicated with medetomidine and midazolam. The Veterinary record. 2019 03; 184(13):411. doi: 10.1136/vr.105070. [PMID: 30926700]
  • Katherine J Bennett, Reza Seddighi, Kaitlin A Moorhead, Kristin Messenger, Sherry K Cox, Xiaocun Sun, Kirby Pasloske, Bruno H Pypendop, Thomas J Doherty. Effect of fentanyl on the induction dose and minimum infusion rate of alfaxalone preventing movement in dogs. Veterinary anaesthesia and analgesia. 2019 Mar; 46(2):173-181. doi: 10.1016/j.vaa.2018.10.006. [PMID: 30554890]
  • Wendy A Goodwin, Kirby Pasloske, Helen L Keates, Millaganamada Gedara Ranasinghe, Solomon Woldeyohannes, Nigel Perkins. Alfaxalone for total intravenous anaesthesia in horses. Veterinary anaesthesia and analgesia. 2019 Mar; 46(2):188-199. doi: 10.1016/j.vaa.2018.09.047. [PMID: 30713053]
  • Hirotaka Tokushige, Asuka Kushiro, Atsushi Okano, Tatsuya Maeda, Hideki Ito, Ai Wakuno, Shun-Ichi Nagata, Minoru Ohta. Clinical evaluation of constant rate infusion of alfaxalone-medetomidine combined with sevoflurane anesthesia in Thoroughbred racehorses undergoing arthroscopic surgery. Acta veterinaria Scandinavica. 2018 Sep; 60(1):50. doi: 10.1186/s13028-018-0406-4. [PMID: 30180855]
  • Bruno H Pypendop, M G Ranasinghe, Kirby Pasloske. Pharmacokinetics of alfaxalone infusions, context-sensitive half-time and recovery times in male neutered cats. Veterinary anaesthesia and analgesia. 2018 Sep; 45(5):630-639. doi: 10.1016/j.vaa.2018.06.003. [PMID: 30057008]
  • D Rodrigo-Mocholí, E Escudero, E Belda, F G Laredo, V Hernandis, P Marín. Pharmacokinetics and effects of alfaxalone after intravenous and intramuscular administration to cats. New Zealand veterinary journal. 2018 Jul; 66(4):172-177. doi: 10.1080/00480169.2018.1455541. [PMID: 29562829]
  • Bruno H Pypendop, M G Ranasinghe, Kirby Pasloske. Comparison of two intravenous anesthetic infusion regimens for alfaxalone in cats. Veterinary anaesthesia and analgesia. 2018 Jul; 45(4):459-466. doi: 10.1016/j.vaa.2018.03.003. [PMID: 29853416]
  • K Pasloske, M G Ranasinghe, S Sauer, J Hare. The bioequivalence of a single intravenous administration of the anesthetic alfaxalone in cyclodextrin versus alfaxalone in cyclodextrin plus preservatives in cats. Journal of veterinary pharmacology and therapeutics. 2018 Jun; 41(3):437-446. doi: 10.1111/jvp.12485. [PMID: 29352472]
  • Bruno H Pypendop, Kristine T Siao, M G Ranasinghe, Kirby Pasloske. Effective plasma alfaxalone concentration to produce immobility in male neutered cats. Veterinary anaesthesia and analgesia. 2018 May; 45(3):269-277. doi: 10.1016/j.vaa.2017.10.006. [PMID: 29415861]
  • Franz Josef Söbbeler, Inés Carrera, Kirby Pasloske, Millagahamada Gedara Ranasinghe, Patrick Kircher, Sabine Beate Rita Kästner. Effects of isoflurane, sevoflurane, propofol and alfaxalone on brain metabolism in dogs assessed by proton magnetic resonance spectroscopy (1H MRS). BMC veterinary research. 2018 Mar; 14(1):69. doi: 10.1186/s12917-018-1396-1. [PMID: 29506576]
  • Inga-Catalina Cruz-Benedetti, Isabelle Bublot, Thibault Ribas, Isabelle Fourel, Claus Vogl, Claire Dubois, Mathilde Milani, Keila Kazue Ida, Karine Portier. Pharmacokinetics of intramuscular alfaxalone and its echocardiographic, cardiopulmonary and sedative effects in healthy dogs. PloS one. 2018; 13(9):e0204553. doi: 10.1371/journal.pone.0204553. [PMID: 30248146]
  • Pavel Y Savechenkov, David C Chiara, Rooma Desai, Alexander T Stern, Xiaojuan Zhou, Alexis M Ziemba, Andrea L Szabo, Yinghui Zhang, Jonathan B Cohen, Stuart A Forman, Keith W Miller, Karol S Bruzik. Synthesis and pharmacological evaluation of neurosteroid photoaffinity ligands. European journal of medicinal chemistry. 2017 Aug; 136(?):334-347. doi: 10.1016/j.ejmech.2017.04.043. [PMID: 28505538]
  • Rachel C Bennett, Kati M Salla, Marja R Raekallio, Mika Scheinin, Outi M Vainio. Effects of the α2-adrenoceptor agonist medetomidine on the distribution and clearance of alfaxalone during coadministration by constant rate infusion in dogs. American journal of veterinary research. 2017 Aug; 78(8):956-964. doi: 10.2460/ajvr.78.8.956. [PMID: 28738010]
  • Kirk A Muñoz, Sheilah A Robertson, Deborah V Wilson. Alfaxalone alone or combined with midazolam or ketamine in dogs: intubation dose and select physiologic effects. Veterinary anaesthesia and analgesia. 2017 Jul; 44(4):766-774. doi: 10.1016/j.vaa.2017.01.004. [PMID: 28756063]
  • Kate L White, Stuart Paine, John Harris. A clinical evaluation of the pharmacokinetics and pharmacodynamics of intravenous alfaxalone in cyclodextrin in male and female rats following a loading dose and constant rate infusion. Veterinary anaesthesia and analgesia. 2017 Jul; 44(4):865-875. doi: 10.1016/j.vaa.2017.01.001. [PMID: 28318987]
  • Colin S Goodchild, Juliet M Serrao, Anton Kolosov, Ben J Boyd. Alphaxalone Reformulated: A Water-Soluble Intravenous Anesthetic Preparation in Sulfobutyl-Ether-β-Cyclodextrin. Anesthesia and analgesia. 2015 May; 120(5):1025-1031. doi: 10.1213/ane.0000000000000559. [PMID: 25517195]
  • Jean-Loup Rault, Kate Plush, Tamara Yawno, Pieter Langendijk. Allopregnanolone and social stress: regulation of the stress response in early pregnancy in pigs. Stress (Amsterdam, Netherlands). 2015; 18(5):569-77. doi: 10.3109/10253890.2015.1047340. [PMID: 26068516]
  • Tamara Yawno, Monique Mortale, Amy E Sutherland, Graham Jenkin, Euan M Wallace, David W Walker, Suzanne L Miller. The effects of betamethasone on allopregnanolone concentrations and brain development in preterm fetal sheep. Neuropharmacology. 2014 Oct; 85(?):342-8. doi: 10.1016/j.neuropharm.2014.05.031. [PMID: 24880086]
  • Andrea Schwarz, Karin Kalchofner, Julia Palm, Stephanie Picek, Sonja Hartnack, Regula Bettschart-Wolfensberger. Minimum infusion rate of alfaxalone for total intravenous anaesthesia after sedation with acepromazine or medetomidine in cats undergoing ovariohysterectomy. Veterinary anaesthesia and analgesia. 2014 Sep; 41(5):480-90. doi: 10.1111/vaa.12144. [PMID: 24575797]
  • C Lau, M G Ranasinghe, I Shiels, H Keates, K Pasloske, M C Bellingham. Plasma pharmacokinetics of alfaxalone after a single intraperitoneal or intravenous injection of Alfaxan(®) in rats. Journal of veterinary pharmacology and therapeutics. 2013 Oct; 36(5):516-20. doi: 10.1111/jvp.12055. [PMID: 23600373]
  • Ping Li, Megan M Eaton, Joe Henry Steinbach, Gustav Akk. The benzodiazepine diazepam potentiates responses of α1β2γ2L γ-aminobutyric acid type A receptors activated by either γ-aminobutyric acid or allosteric agonists. Anesthesiology. 2013 Jun; 118(6):1417-25. doi: 10.1097/aln.0b013e318289bcd3. [PMID: 23407108]
  • Wendy Goodwin, Helen Keates, Kirby Pasloske, Martin Pearson, Ben Sauer, Millagahamada G Ranasinghe. Plasma pharmacokinetics and pharmacodynamics of alfaxalone in neonatal foals after an intravenous bolus of alfaxalone following premedication with butorphanol tartrate. Veterinary anaesthesia and analgesia. 2012 Sep; 39(5):503-10. doi: 10.1111/j.1467-2995.2012.00734.x. [PMID: 22642499]
  • Joanne N Michou, Elizabeth A Leece, Jacqueline C Brearley. Comparison of pain on injection during induction of anaesthesia with alfaxalone and two formulations of propofol in dogs. Veterinary anaesthesia and analgesia. 2012 May; 39(3):275-81. doi: 10.1111/j.1467-2995.2012.00709.x. [PMID: 22414225]
  • Nilufar Foadi, Igor Pilawski, Vanessa Buchholz, Jeanne de la Roche, Florian Wegner, Andreas Leffler, Jörg Ahrens, Sabine Kästner. Interaction of alfaxalone with the neuronal and the skeletal muscle sodium channel. Pharmacology. 2012; 89(5-6):295-302. doi: 10.1159/000337737. [PMID: 22538831]
  • Wendy A Goodwin, Helen L Keates, Kirby Pasloske, Martin Pearson, Ben Sauer, Millaganamada Gedara Ranasinghe. The pharmacokinetics and pharmacodynamics of the injectable anaesthetic alfaxalone in the horse. Veterinary anaesthesia and analgesia. 2011 Sep; 38(5):431-8. doi: 10.1111/j.1467-2995.2011.00634.x. [PMID: 21831048]
  • Jasenka Guduric-Fuchs, Wing Chen, Henrietta Price, Desmond B Archer, Tiziana Cogliati. RPE and neuronal differentiation of allotransplantated porcine ciliary epithelium-derived cells. Molecular vision. 2011; 17(?):2580-95. doi: NULL. [PMID: 22025893]
  • Gustav Akk, Douglas F Covey, Alex S Evers, Joe Henry Steinbach, Charles F Zorumski, Steven Mennerick. The influence of the membrane on neurosteroid actions at GABA(A) receptors. Psychoneuroendocrinology. 2009 Dec; 34 Suppl 1(?):S59-66. doi: 10.1016/j.psyneuen.2009.05.020. [PMID: 19541427]
  • K Pasloske, B Sauer, N Perkins, T Whittem. Plasma pharmacokinetics of alfaxalone in both premedicated and unpremedicated Greyhound dogs after single, intravenous administration of Alfaxan at a clinical dose. Journal of veterinary pharmacology and therapeutics. 2009 Oct; 32(5):510-3. doi: 10.1111/j.1365-2885.2009.01070.x. [PMID: 19754921]
  • T Whittem, K S Pasloske, M C Heit, M G Ranasinghe. The pharmacokinetics and pharmacodynamics of alfaxalone in cats after single and multiple intravenous administration of Alfaxan at clinical and supraclinical doses. Journal of veterinary pharmacology and therapeutics. 2008 Dec; 31(6):571-9. doi: 10.1111/j.1365-2885.2008.00998.x. [PMID: 19000281]
  • Thomas M Mavromoustakos. The use of differential scanning calorimetry to study drug-membrane interactions. Methods in molecular biology (Clifton, N.J.). 2007; 400(?):587-600. doi: 10.1007/978-1-59745-519-0_39. [PMID: 17951761]
  • Pierre J Ferré, Kirby Pasloske, Ted Whittem, Millagahamanda G Ranasinghe, Qiang Li, Hervé P Lefebvre. Plasma pharmacokinetics of alfaxalone in dogs after an intravenous bolus of Alfaxan-CD RTU. Veterinary anaesthesia and analgesia. 2006 Jul; 33(4):229-36. doi: 10.1111/j.1467-2995.2005.00264.x. [PMID: 16764587]
  • C J Weir, A T Y Ling, D Belelli, J A W Wildsmith, J A Peters, J J Lambert. The interaction of anaesthetic steroids with recombinant glycine and GABAA receptors. British journal of anaesthesia. 2004 May; 92(5):704-11. doi: 10.1093/bja/aeh125. [PMID: 15033889]
  • S A G Visser, D R H Huntjens, P H van der Graaf, L A Peletier, M Danhof. Mechanism-based modeling of the pharmacodynamic interaction of alphaxalone and midazolam in rats. The Journal of pharmacology and experimental therapeutics. 2003 Nov; 307(2):765-75. doi: 10.1124/jpet.103.054510. [PMID: 12975494]
  • Takafumi Horishita, Kouichiro Minami, Nobuyuki Yanagihara, Munehiro Shiraishi, Takashi Okamoto, Yousuke Shiga, Susumu Ueno, Akio Shigematsu. Alphaxalone, a neurosteroid anesthetic, inhibits norepinephrine transporter function in cultured bovine adrenal medullary cells. Anesthesia and analgesia. 2002 Dec; 95(6):1661-6, table of contents. doi: 10.1097/00000539-200212000-00034. [PMID: 12456434]
  • S A G Visser, W W F T Gladdines, P H van der Graaf, L A Peletier, M Danhof. Neuroactive steroids differ in potency but not in intrinsic efficacy at the GABA(A) receptor in vivo. The Journal of pharmacology and experimental therapeutics. 2002 Nov; 303(2):616-26. doi: 10.1124/jpet.102.039610. [PMID: 12388643]
  • Kinga K Borowicz, Marek Zadrozniak, Mariusz Swiader, Aneta Kowalska, Zdzisław Kleinrok, Stanisław J Czuczwar. Interaction of the neurosteroid alphaxalone with conventional antiepileptic drugs in different types of experimental seizures. European journal of pharmacology. 2002 Aug; 449(1-2):85-90. doi: 10.1016/s0014-2999(02)01975-1. [PMID: 12163110]
  • S A Visser, C J Smulders, W W Gladdines, H Irth, P H van der Graaf, M Danhof. High-performance liquid chromatography of the neuroactive steroids alphaxalone and pregnanolone in plasma using dansyl hydrazine as fluorescent label: application to a pharmacokinetic-pharmacodynamic study in rats. Journal of chromatography. B, Biomedical sciences and applications. 2000 Aug; 745(2):357-63. doi: 10.1016/s0378-4347(00)00296-6. [PMID: 11043754]
  • T Mavromoustakos, E Theodoropoulou, D P Yang. The use of high-resolution solid-state NMR spectroscopy and differential scanning calorimetry to study interactions of anaesthetic steroids with membrane. Biochimica et biophysica acta. 1997 Aug; 1328(1):65-73. doi: 10.1016/s0005-2736(97)00078-3. [PMID: 9298946]
  • L Koetzner, R L Riggs, J Mastropaolo, S I Deutsch. Selective cyclodextrin inhibition of alfaxolone-induced ataxia. The Journal of pharmacy and pharmacology. 1996 May; 48(5):529-31. doi: 10.1111/j.2042-7158.1996.tb05968.x. [PMID: 8799881]
  • T Mavromoustakos, D P Yang, A Makriyannis. Effects of the anesthetic steroid alphaxalone and its inactive delta 16-analog on the thermotropic properties of membrane bilayers. A model for membrane perturbation. Biochimica et biophysica acta. 1995 Nov; 1239(2):257-64. doi: 10.1016/0005-2736(95)00153-t. [PMID: 7488631]
  • A Y Valeyev, V S Dunlap, J L Barker. Pharmacological properties of fetal rat hippocampal GABAA receptors. Brain research. Developmental brain research. 1995 Apr; 85(2):280-2. doi: 10.1016/0165-3806(94)00200-j. [PMID: 7600675]
  • B D Harris, G Wong, E J Moody, P Skolnick. Different subunit requirements for volatile and nonvolatile anesthetics at gamma-aminobutyric acid type A receptors. Molecular pharmacology. 1995 Feb; 47(2):363-7. doi: . [PMID: 7870045]
  • T Mavromoustakos, D P Yang, A Makriyannis. Topography of alphaxalone and delta 16-alphaxalone in membrane bilayers containing cholesterol. Biochimica et biophysica acta. 1994 Aug; 1194(1):69-74. doi: 10.1016/0005-2736(94)90204-6. [PMID: 8075143]
  • I Ueda, T Tatara, J S Chiou, P R Krishna, H Kamaya. Structure-selective anesthetic action of steroids: anesthetic potency and effects on lipid and protein. Anesthesia and analgesia. 1994 Apr; 78(4):718-25. doi: 10.1213/00000539-199404000-00018. [PMID: 8135392]
  • T P Dean, R C Hider. Incorporation of alphaxalone into different types of liposomes. The Journal of pharmacy and pharmacology. 1993 Nov; 45(11):990-2. doi: 10.1111/j.2042-7158.1993.tb05643.x. [PMID: 7908044]
  • T Tatara. [The anesthetic effects of steroids and their actions on the properties of model membrane]. Masui. The Japanese journal of anesthesiology. 1992 Sep; 41(9):1419-25. doi: ". [PMID: 1433872]
  • K T Britton, S McLeod, G F Koob, R Hauger. Pregnane steroid alphaxalone attenuates anxiogenic behavioral effects of corticotropin releasing factor and stress. Pharmacology, biochemistry, and behavior. 1992 Feb; 41(2):399-403. doi: 10.1016/0091-3057(92)90117-x. [PMID: 1315440]
  • A Makriyannis, C M DiMeglio, S W Fesik. Anesthetic steroid mobility in model membrane preparations as examined by high-resolution 1H and 2H NMR spectroscopy. Journal of medicinal chemistry. 1991 May; 34(5):1700-3. doi: 10.1021/jm00109a024. [PMID: 2033593]
  • A Makriyannis, D P Yang, T Mavromoustakos. The molecular features of membrane perturbation by anaesthetic steroids: a study using differential scanning calorimetry, small angle X-ray diffraction and solid state 2H NMR. Ciba Foundation symposium. 1990; 153(?):172-84; discussion 185. doi: 10.1002/9780470513989.ch10. [PMID: 2292211]
  • I P Johnstone, B J Bancroft. The effects of different anesthetics on blood steroid concentrations in domestic tom-cats. Australian veterinary journal. 1988 Dec; 65(12):382-5. doi: 10.1111/j.1751-0813.1988.tb14278.x. [PMID: 3223851]
  • E Benoit, M R Carratù, D Mitolo-Chieppa. Interactions between molecules of a steroid anaesthetic (alphaxalone) and ionic channels of nodal membrane in voltage-clamped myelinated nerve fibre. British journal of pharmacology. 1988 Jul; 94(3):635-46. doi: 10.1111/j.1476-5381.1988.tb11570.x. [PMID: 2460175]
  • M A Emanuele, J Tentler, L Kirsteins, D Reda, N V Emanuele, A M Lawrence. Anaesthesia with alphaxalone plus alphadolone acetate decreases serum concentrations of LH in castrated rats. The Journal of endocrinology. 1987 Nov; 115(2):221-3. doi: 10.1677/joe.0.1150221. [PMID: 3437247]
  • A Makriyannis, D J Siminovitch, S K Das Gupta, R G Griffin. Studies on the interaction of anesthetic steroids with phosphatidylcholine using 2H and 13C solid state NMR. Biochimica et biophysica acta. 1986 Jul; 859(1):49-55. doi: 10.1016/0005-2736(86)90316-0. [PMID: 3755060]
  • A Bendtsen, A Kruse, J B Madsen, J Astrup, J Rosenørn, B Blatt-Lyon, G E Cold. Use of a continuous infusion of althesin in neuroanaesthesia. Changes in cerebral blood flow, cerebral metabolism, the EEG and plasma alphaxalone concentration. British journal of anaesthesia. 1985 Apr; 57(4):369-74. doi: 10.1093/bja/57.4.369. [PMID: 3986065]
  • A K Brar, A S McNeilly, G Fink. Effects of hyperprolactinaemia and testosterone on the release of LH-releasing hormone and the gonadotrophins in intact and castrated rats. The Journal of endocrinology. 1985 Jan; 104(1):35-43. doi: 10.1677/joe.0.1040035. [PMID: 3918133]
  • T J O'Leary, P D Ross, I W Levin. Effects of anesthetic and nonanesthetic steroids on dipalmitoylphosphatidylcholine liposomes: a calorimetric and Raman spectroscopic investigation. Biochemistry. 1984 Sep; 23(20):4636-41. doi: 10.1021/bi00315a019. [PMID: 6548642]
  • R G Dyer, S Mansfield. Anaesthesia with alphaxalone plus alphadolone acetate blocks the oestrogen-stimulated LH surge and impairs pulsatile LH secretion in ovariectomized female rats. The Journal of endocrinology. 1984 Jul; 102(1):27-31. doi: 10.1677/joe.0.1020027. [PMID: 6736851]
  • G O Stewart, G J Dobb, I A Craib. Clinical trial of continuous infusion of alphaxalone/alphadolone in intensive care patients. Anaesthesia and intensive care. 1983 May; 11(2):107-12. doi: 10.1177/0310057x8301100203. [PMID: 6346940]
  • A Makriyannis, S Fesik. Mechanism of steroid anesthetic action: interactions of alphaxalone and delta 16-alphaxalone with bilayer vesicles. Journal of medicinal chemistry. 1983 Apr; 26(4):463-5. doi: 10.1021/jm00358a001. [PMID: 6834378]
  • J Descotes, P Tachon, A Laschi-Locquerie, J C Evreux. Adjuvancy of Cremophor Elo in rodents. International archives of allergy and applied immunology. 1983; 72(3):287-8. doi: 10.1159/000234883. [PMID: 6618686]
  • M Frank, T M Savege, M Leigh, J Greenwood, J M Holly. Comparison of the cerebral function monitor and plasma concentrations of thiopentone and alphaxalone during total i.v. anaesthesia with repeated bolus doses of thiopentone and althesin. British journal of anaesthesia. 1982 Jun; 54(6):609-16. doi: 10.1093/bja/54.6.609. [PMID: 7082524]
  • J M Holly, D J Trafford, J W Sear, H L Makin. The in vivo metabolism of Althesin (alphaxalone + alphadolone acetate) in man. The Journal of pharmacy and pharmacology. 1981 Jul; 33(7):427-33. doi: 10.1111/j.2042-7158.1981.tb13827.x. [PMID: 6115029]
  • M E Jones, T E Nicholas. The pharmacokinetics of the intravenous steroid anesthetic alphaxalone in the isolated perfused rat lung. Journal of pharmacokinetics and biopharmaceutics. 1981 Jun; 9(3):343-55. doi: 10.1007/bf01059270. [PMID: 7288594]
  • J W Sear, J M Holly, D J Trafford, H L Makin. Plasma concentrations of alphaxalone by gas chromatography: comparison with other gas chromatographic methods and gas chromatography-mass spectrometry. The Journal of pharmacy and pharmacology. 1980 May; 32(5):349-52. doi: 10.1111/j.2042-7158.1980.tb12934.x. [PMID: 6104701]